文献速递疼痛医学神经外科与老年麻醉

颈交感神经阻滞治疗长新冠:范围综述

Cervical sympathetic block to treat Long COVID: a scoping review.
PubMed 文献 · Reg Anesth Pain Med · 2026-08-05

多数研究报道疲劳、脑雾和自主神经症状改善,认知精神症状改善不一,嗅觉恢复不一致,未见严重并发症。证据仍属初步,受样本量小和方法异质性限制,需对照试验确认疗效和患者选择标准。

要点

  • CSB可能改善长新冠患者的疲劳、脑雾和自主神经功能障碍。
  • 认知精神症状改善不一,嗅觉恢复不一致且似与症状严重程度相关。
  • 单侧和双侧阻滞后均见症状缓解,部分反应持续长达1年,无严重并发症。

核心结论

  • CSB可能为长新冠患者提供症状缓解,尤其是疲劳、脑雾和自主神经功能障碍。
  • 证据仍属初步,受小样本和方法异质性限制,需对照试验确立疗效和患者选择标准。

研究设计与样本

  • 范围综述,结构化检索PubMed、Embase、Scopus和Web of Science,纳入2022年至2025年3月发表的文献。

主要发现

  • 多数研究报道疲劳、脑雾和自主神经症状改善,包括心率降低和直立耐受性增强。
  • 记忆障碍、焦虑和抑郁等认知精神症状改善不一。
  • 嗅觉恢复不一致,似取决于症状严重程度。
  • 单侧和双侧阻滞后均观察到症状缓解,部分反应持续长达1年,未报告严重并发症。

临床怎么用

  • CSB可作为长新冠疲劳、脑雾和自主神经功能障碍的潜在辅助治疗选择。
  • 认知精神症状和嗅觉障碍的疗效不确定,需个体化评估。

局限性

  • 样本量小。
  • 方法异质性大,证据属初步。
  • 需对照试验确立疗效和患者选择标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long COVID is a complex and poorly understood condition characterized by persistent symptoms such as autonomic dysfunction, fatigue, neurocognitive impairment, and olfactory disturbances. Current treatments offer limited and inconsistent benefits. Dysregulation of the sympathetic nervous system is increasingly recognized as a contributor to Long COVID pathophysiology. Cervical sympathetic block (CSB), a procedure that modulates sympathetic tone, has emerged as a potential therapeutic approach. OBJECTIVE: To review the existing literature on CSB, for Long COVID, focusing on symptom outcomes, proposed mechanisms, and procedural considerations. EVIDENCE REVIEW: A structured literature search across PubMed, Embase, Scopus, and Web of Science identified studies published between 2022 and March 2025 reporting on CSB in adults with Long COVID. Eligible articles included case reports, case series, observational studies, and one randomized controlled trial evaluating symptom outcomes after the procedure. FINDINGS: Sixteen studies involving 224 patients were included. Most reported improvement in fatigue, brain fog, and autonomic symptoms, including reduced heart rate and enhanced orthostatic tolerance. Cognitive and psychiatric symptoms such as memory impairment, anxiety, and depression showed variable improvement. Olfactory recovery was inconsistent and appeared to depend on symptom severity. Symptom relief was observed after both unilateral and bilateral blocks, with some responses lasting up to 1 year. No serious complications were reported. CONCLUSIONS: CSB may offer symptom relief in Long COVID, particularly for fatigue, brain fog, and dysautonomia. However, the evidence remains preliminary and limited by small sample sizes and methodological heterogeneity. Controlled trials are needed to establish efficacy and patient selection criteria.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Bombardieri AM, Denoue CF. Cervical sympathetic block to treat Long COVID: a scoping review. Reg Anesth Pain Med. 2026. PMID: 40866305. doi:10.1136/rapm-2025-106879

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。